VLTO:NYSEVeralto Corp Analysis
Data as of 2026-03-10 - not real-time
$91.79
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Veralto is currently trading below its short‑term moving average while still above its mid‑term average, signaling a short‑term bearish bias. The momentum indicator sits in a low‑mid range, hinting at limited upside, yet the MACD has just turned bullish, offering a modest counter‑signal. Declining volume reinforces the bearish technical outlook. On the fundamentals side, the company posted an earnings beat and improved margins, supported by strong cash generation and a low dividend payout ratio, which suggests dividend sustainability. However, the discounted cash‑flow model values the firm well below the market price, implying that the stock may be overvalued at present. Recent guidance was cautious, tempering enthusiasm despite the earnings surprise. The sector’s exposure to environmental regulation adds a layer of risk, while the firm’s diversified water‑treatment and product‑quality businesses provide a stable revenue base. Overall, the mix of technical weakness, overvaluation signals, and solid fundamentals creates a nuanced investment picture.
Investors should weigh the near‑term downside risk against the longer‑term upside potential reflected in analyst price targets and the company’s strong cash flow and dividend profile. A cautious stance is warranted until price action shows clearer signs of a sustainable recovery.
Investors should weigh the near‑term downside risk against the longer‑term upside potential reflected in analyst price targets and the company’s strong cash flow and dividend profile. A cautious stance is warranted until price action shows clearer signs of a sustainable recovery.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near immediate support level
- decreasing trading volume
- cautious forward guidance
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- earnings beat and margin expansion
- strong operating and free cash flow
- potential upside toward analyst price targets
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- high return on equity and consistent profitability
- strategic acquisitions expanding water‑treatment capabilities
- sustainable dividend with low payout ratio
Key Metrics & Analysis
Financial Health
Revenue Growth3.80%
Profit Margin17.08%
P/E Ratio24.4
ROE36.50%
ROA11.34%
Debt/Equity92.69
P/B Ratio7.3
Op. Cash Flow$1.1B
Free Cash Flow$815.4M
Industry P/E29.4
Technical Analysis
TrendBearish
RSI38.5
Support$91.33
Resistance$98.08
MA 20$94.24
MA 50$97.45
MA 200$101.42
MACDBullish
VolumeDecreasing
Fear & Greed Index76.91
Valuation
Fair Value$50.35
Target Price$110.12
Upside/Downside19.97%
GradeOvervalued
TypeBlend
Dividend Yield0.55%
Risk Assessment
Beta0.71
Volatility32.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.